Profile data is unavailable for this security.
About the company
Microba Life Sciences Limited is an Australia-based precision microbiome company. The Company is engaged in the discovery and development of therapeutics for major chronic diseases and delivers gut microbiome testing services globally to researchers, clinicians, and consumers. It offers various platforms, such as Analysis, Discovery, and Therapeutic. Through its analysis and discovery platforms, it identifies microbiome-derived therapeutics and diagnostic tools to advance medicine. Through its Analysis Platform, it generates a global databank of microbiome samples and associated metadata to develop new health solutions. Its Discovery Platform enables partners to access this databank for the data-driven discovery of product opportunities. Its therapeutic platform is a repeatable platform for microbial therapeutic leads. It also offers a product portfolio of gastrointestinal, vaginal, oral, and urinary microbiome testing, together with a targeted set of evidence-based formulations.
- Revenue in AUD (TTM)6.54m
- Net income in AUD-18.49m
- Incorporated2017
- Employees--
- LocationMicroba Life Sciences Ltd324 Queen Street, Level 10BRISBANE 4000AustraliaAUS
- Phone+61 73222-8444
- Websitehttps://www.microba.com/
Mergers & acquisitions
| Acquired company | MAP:ASX since announced | Transaction value |
|---|---|---|
| Invivo Clinical Ltd | -33.33% | 13.49m |
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Emyria Ltd | 1.95m | -11.95m | 18.70m | -- | -- | 19.68 | -- | 9.59 | -0.0363 | -0.0363 | 0.0062 | 0.0026 | 0.275 | -- | 49.60 | -- | -168.58 | -77.78 | -321.66 | -93.49 | -12.45 | -45.04 | -612.98 | -388.17 | -- | -30.01 | 0.7573 | -- | -12.62 | -- | 29.98 | -- | -- | -- |
| Artrya Ltd | 0.00 | -11.56m | 24.00m | -- | -- | 1.01 | -- | -- | -0.1472 | -0.1472 | 0.00 | 0.3021 | 0.00 | -- | -- | -- | -36.17 | -- | -38.11 | -- | -- | -- | -- | -- | -- | -- | 0.0435 | -- | -- | -- | 35.09 | -- | -- | -- |
| Cryosite Ltd | 12.61m | 1.58m | 40.02m | 34.00 | 25.42 | 13.82 | 17.27 | 3.17 | 0.0323 | 0.0323 | 0.2582 | 0.0593 | 0.5912 | 74.83 | 7.30 | -- | 7.39 | 4.12 | 8.99 | 4.88 | 60.85 | 53.88 | 12.50 | 8.56 | 2.29 | -- | 0.4487 | -- | 1.51 | 15.04 | 3.30 | -- | 10.72 | -- |
| Microba Life Sciences Ltd | 6.54m | -18.49m | 80.61m | -- | -- | 1.64 | -- | 12.32 | -0.0502 | -0.0502 | 0.0178 | 0.11 | 0.1119 | 2.67 | 9.26 | -- | -31.64 | -- | -37.61 | -- | 46.55 | -- | -282.64 | -- | 3.11 | -- | 0.0272 | -- | 15.60 | -- | -10.55 | -- | -- | -- |
| Eureka Group Holdings Ltd | 39.24m | 17.71m | 159.93m | 42.00 | 9.04 | 1.08 | 8.63 | 4.08 | 0.0587 | 0.0587 | 0.13 | 0.4907 | 0.1626 | -- | 64.27 | -- | 7.34 | 6.02 | 7.54 | 6.21 | 53.43 | 50.40 | 45.13 | 33.60 | -- | -- | 0.3849 | 24.62 | 22.42 | 10.04 | 134.41 | -- | 91.86 | -- |
| Capitol Health Ltd | 229.29m | 6.14m | 255.85m | -- | 41.81 | 1.91 | 7.77 | 1.12 | 0.0057 | 0.0057 | 0.214 | 0.1256 | 0.7237 | -- | 47.34 | -- | 1.97 | 3.05 | 2.27 | 3.55 | 92.94 | 92.41 | 2.73 | 4.24 | -- | -- | 0.5219 | 130.91 | 13.81 | 11.90 | -203.87 | -- | 19.92 | 4.56 |
| Australian Unity Ltd | 2.00bn | 43.47m | 280.21m | 7.70k | -- | -- | 2.89 | 0.1402 | -- | -- | -- | -- | 0.2346 | -- | -- | 259,666.80 | 0.5105 | 0.5917 | -- | -- | -- | -- | 2.18 | 2.65 | -- | 2.25 | 0.6373 | -- | 36.50 | 12.70 | 24.19 | -- | -5.72 | -- |
| Pacific Smiles Group Ltd | 173.72m | 6.61m | 301.61m | 800.00 | 43.16 | 5.01 | 8.01 | 1.74 | 0.0438 | 0.0438 | 1.09 | 0.3774 | 0.9257 | 3.88 | 57.63 | -- | 3.52 | 3.61 | 4.44 | 4.55 | 86.25 | 85.00 | 3.80 | 3.68 | 0.5689 | 2.95 | 0.5862 | 78.81 | 18.54 | 9.60 | 153.43 | -18.18 | -4.27 | -15.55 |
| Holder | Shares | % Held |
|---|---|---|
| Perennial Value Management Ltd.as of 22 Feb 2024 | 66.27m | 14.80% |
| Thorney Investment Group Australia Pty Ltd.as of 14 Aug 2023 | 26.13m | 5.84% |
| Norges Bank Investment Managementas of 31 Dec 2023 | 13.44m | 3.00% |
| Sandhurst Trustees Ltd.as of 14 Aug 2023 | 2.93m | 0.66% |
